首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Tachycardia control in septic shock with esmolol and ivabradine: a comparison on heart function
【24h】

Tachycardia control in septic shock with esmolol and ivabradine: a comparison on heart function

机译:艾司洛尔和伊伐布雷定控制败血症性休克的心动过速:心功能的比较

获取原文

摘要

Persisting tachycardia is often observed in resuscitated septic shock patients, and it is an independent risk factor for increased mortality. Recently, several drugs, such as esmolol and ivabradine, have been proved to be beneficial in HR control, but their overall impact on cardiac functions needs further investigation. The aim of this study is to study the effects of the two drugs on heart function in a protocol of polymicrobial septic shock and resuscitation. Twelve pigs were divided into three experimental groups: the esmolol-treated group (n=4), the ivabradine-treated group (n=5) and the control group (n=3). Cardiac autonomic activity was estimated by heart rate variability (HRV) indices and baroreflex sensitivity (BRS). The Buckberg index was adopted to evaluate myocardial oxygenation efficiency. Septic shock induced a severe autonomic dysfunction and a lower cardiac efficiency, not resolved by fluids resuscitation. The administration of the drugs improved both the HRV and the BRS, but this favourable condition was preserved after noradrenaline administration only in the esmolol group. The interaction of esmolol with the autonomic system is beneficial in septic shock to restore an improved condition of HRV and control, while ivabradine is not as effective when administered in adjunction to noradrenaline.
机译:在复苏的败血性休克患者中经常观察到持续性心动过速,这是增加死亡率的独立危险因素。最近,已证实几种药物,如艾司洛尔和伊伐布雷定,对控制心率是有益的,但它们对心脏功能的总体影响尚需进一步研究。这项研究的目的是在微生物败血症性休克和复苏方案中研究这两种药物对心脏功能的影响。将十二只猪分为三个实验组:艾司洛尔治疗组(n = 4),伊伐布雷定治疗组(n = 5)和对照组(n = 3)。通过心率变异性(HRV)指数和压力反射敏感性(BRS)评估心脏自主神经活动。采用Buckberg指数评估心肌的充氧效率。败血性休克引起严重的自主神经功能障碍和心脏效率降低,而液体复苏并不能解决。药物的施用改善了HRV和BRS,但是仅在艾司洛尔组中去甲肾上腺素施用后,保留了这种有利条件。艾司洛尔与自主系统的相互作用有利于败血性休克恢复HRV和控制的改善,而伊伐布雷定与去甲肾上腺素同时给药效果不佳。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号